Prominent heightened arousal symptoms and clinical/laboratory findings
implicate the central noradrenergic system in posttraumatic stress di
sorder (PTSD), Heightened arousal frequently manifests in relation to
sleep in PTSD. Central noradrenergic systems have a role in regulating
arousal levels during sleep, We therefore evaluated noradrenergic pro
duction via urinary excretion in relation to sleep/wake activity in PT
SD patients and controls, Twenty patients-all Vietnam veterans diagnos
ed with combat-related PTSD-and eight non-ill, non-combat-exposed cont
rols had overnight sleep studies under medication and substance-free c
onditions. In association with sleep recording, subjects saved their u
rine for 24 hours in three 8-hour collections in order to obtain ''day
time'' (8:00 AM to 4:00 PM, 4:00 PM to MN) and ''nocturnal'' (MN to 8:
00 AM) catecholamine measures. PTSD patients had decreased sleep effic
iency relative to controls and increased REM density; 24-hour norepine
phrine and MHPG (the more centrally derived metabolite) did not differ
between patients and controls. ''Nocturnal'' excretion of MHPG minus
the average of the two ''daytime'' values was negative in the controls
, slightly positive in the patients, and differed significantly betwee
n the two groups. ''Nocturnal minus daytime'' MHPG also correlated neg
atively with total sleep time in the PTSD patients (R = -.45, p < .05)
, Our data support a relationship of nondiminished central noradrenerg
ic activity at night, and sleep disturbance, in chronic combat-related
PTSD.